Keyphrases
Patient Survival
100%
MicroRNA
100%
Drug Response
100%
Phosphatidylinositol 3-kinase Inhibitor
100%
Wide Crosses
100%
Survival Response
100%
Cancer Analysis
100%
MiR-105
42%
Cancer Types
28%
Overexpression
14%
Functional Consequences
14%
Potential Functional
14%
Statistical Techniques
14%
Modeling Approach
14%
Bimodal Distribution
14%
In Cancer
14%
Path Analysis
14%
Chemotherapy Treatment
14%
Expressed Genes
14%
Inhibitor Treatment
14%
Clinical Significance
14%
High-level Expression
14%
Drug Target
14%
Two-mode
14%
Cancer Tumor
14%
Cancer Patients
14%
Personalized Therapy
14%
Bimodality
14%
Lung Cancer
14%
Genetic Heterogeneity
14%
Cancer Drugs
14%
Metabolic Pathway Analysis
14%
Healthy Controls
14%
Cancer Heterogeneity
14%
Single Population
14%
Liver Cancer
14%
Patient-controlled
14%
Sample Mean
14%
Poor Prognosis
14%
Expression Mode
14%
Overexpression Experiments
14%
Mixture Modeling
14%
Oncogenic microRNA
14%
Phosphoinositide 3-kinase Pathway
14%
Medicine and Dentistry
Malignant Neoplasm
100%
microRNA
100%
Drug Response
100%
Phosphoinositide 3-Kinase Inhibitor
100%
Neoplasm
11%
Cell Line
11%
In Vitro
11%
Carcinogenesis
11%
Cancer
11%
Biological Marker
11%
Personalized Medicine
11%
Lung Cancer
11%
Genetic Heterogeneity
11%
Phosphoinositide 3-Kinase
11%
Liver Cancer
11%
Drug Delivery System
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
microRNA
100%
Phosphatidylinositol 3 Kinase Inhibitor
100%
Drug Delivery System
11%
Neoplasm
11%
Carcinogenesis
11%
Chemotherapy
11%
Biological Marker
11%
Lung Cancer
11%
Phosphatidylinositol 3 Kinase
11%
Liver Cancer
11%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Drug Response
100%
Phosphoinositide 3-Kinase Inhibitor
100%
Carcinogenesis
12%
Drug Targeting
12%
Genetic Heterogeneity
12%
Phosphoinositide 3-Kinase
12%